Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues-Reference-Cited by-同舟云学术

Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues

Published:2016-01-12 Issue:6 Volume:7 Page:7096-7109
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cheng Xiao Jiao¹,Lin Jia Cheng¹,Ding Yan Fei²,Zhu Liming¹,Ye Jing³,Tu Shui Ping¹

Affiliation:

1. Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

2. Department of Gastroenterology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

3. Pôle Sino-Français de Recherches en Sciences du Vivant et Génomique, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing drug and cell line representations via contrastive learning for improved anti-cancer drug prioritization;npj Precision Oncology;2024-05-18

2. Current and future prospective of caspases targeting in cancer therapy;Caspases as Molecular Targets for Cancer Therapy;2024

3. In Vivo Stem Cell Discoveries: Promising Implications in Cancer Therapy;Journal of Lab Animal Research;2023-10-25

4. Single-Cell Analysis of CX3CR1+ Cells Reveals a Pathogenic Role for BIRC5+ Myeloid Proliferating Cells Driven by Staphylococcus aureus Leukotoxins;The Journal of Immunology;2023-07-19

5. Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension;Frontiers in Pharmacology;2023-04-24